Sektorsvärderingar Charles River Laboratories International, Inc. CBOE
Aktier
CRL
US1598641074
Bioteknik och medicinsk forskning
|
Marknaden stängd -
CBOE
21.59.50 2026-08-21
|
5-dagars förändring | Förändring 1 jan. | ||
| 295,33 USD | +1,32 % |
|
+5,47 % | +47,92 % |
Huvudkonkurrenter
Lägg till i en lista 0 vald | P/E-tal (Y) | Pris till bok (Y) | PEG (Y) | EV / Försäljning (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Avkastning (Y) | Kapi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 34.78x | 4.63x | 1.34x | 6.2x | 18.42x | 25.92x | 0,92 % | 51,61 md | |
| -21.47x | 22.73x | -0.34x | 297.59x | -22.09x | -21.08x | -.--% | 44,89 md | |
| 33.46x | 6.11x | -35.05x | 3.25x | 14.02x | 21.19x | -.--% | 42,77 md | |
| 49.05x | 8.3x | 0.24x | 5.7x | 31.17x | 36.01x | -.--% | 42,58 md | |
| 29.21x | 2.38x | 0.6x | 8.45x | 21.35x | 25.33x | 0,39 % | 31,82 md | |
| 35.3x | 25.33x | 2.34x | 5.79x | 26.33x | 27.54x | -.--% | 17,33 md | |
| 24.28x | 2.72x | 0.7x | 2.11x | 9.13x | 14.12x | 1,11 % | 14,76 md | |
| 78.97x | 4.68x | -0.35x | 4.14x | 16.07x | 19.74x | -.--% | 14,09 md | |
| 29.18x | 1.38x | 0.28x | 1.92x | 11.79x | 13.42x | -.--% | 13,29 md | |
| 44.56x | 5.09x | 3.04x | 5.2x | 21.89x | 34.36x | 0,51 % | 12,06 md | |
| -50.96x | 26.66x | -43.54x | 8.55x | 209.18x | -2783.49x | -.--% | 13,12 md | |
| 60.77x | 5.19x | 0.38x | 9.32x | 26.5x | 28.95x | 0,44 % | 11,34 md | |
| -28.7x | 8.45x | 1.08x | 112.41x | -32x | -55.68x | -.--% | 11,12 md | |
| -27.06x | 9.35x | -8.86x | 11343.53x | -22.41x | -22.07x | -.--% | 10,49 md | |
| -28.9x | 9.28x | -2.76x | - | -25.52x | -25.58x | -.--% | 10,16 md | |
| -31.1x | 8.99x | -7.11x | 81.55x | -20.73x | -20.18x | -.--% | 9,96 md | |
| -16.41x | 691.6x | -0.31x | 10.76x | -17.24x | -16.64x | -.--% | 9,93 md | |
| 33.58x | - | -0.1x | 17.57x | 32.37x | 31.59x | -.--% | 9,99 md | |
| Genomsnitt | 13,81x | 49,58x | −4,91x | 701,41x | 16,57x | −148,14x | 0,19 % | 20,63 md | |
| Viktad genomsnitt av Capi. | 19,59x | 28,30x | −5,60x | 377,15x | 16,00x | −86,58x | 0,24 % |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
